Case-Control Study: Cannabis Use Associated With Decreased Glaucoma Risk

Frequent cannabis use is linked to a lower chance of a glaucoma diagnosis, according to a case-control study in the Journal of Glaucoma. University of California San Diego researchers compared over 5,000 patients with over 20,000 controls and found marijuana use tied to lower odds of primary open-angle glaucoma, with the effect growing alongside use.
Why it matters: The finding is an association, not proof that cannabis protects eyes, and the authors call only for more research into cannabis components as add-on therapies. Cannabis is known to lower eye pressure only temporarily, and the American Glaucoma Society still does not endorse it as treatment, so patients should not read this as a green light.
The background in California
California is home to the researchers behind this study, who are affiliated with the University of California at San Diego. The state's rules on cannabis use are among the most established in the country.
Adults 21 and older can possess, use and grow cannabis in California. People 18 and older can use it medicinally with a physician's recommendation. Medicinal users get higher possession limits and may buy and grow more if their physician recommends it. A state ID card is voluntary.
For adult use, the possession limit is 28.5 grams of cannabis and 8 grams of concentrated cannabis. Qualified medical patients may hold up to 8 ounces of dried cannabis, or more with a physician's recommendation. Adults 21 and older may grow up to 6 plants at home, though cities and counties may require permits or indoor-only growing.
Retailers, whether storefront or delivery, must be licensed by the Department of Cannabis Control. Buyers must be 21 or older, or 18 and older with a physician's recommendation. The state's License Search Tool at search.cannabis.ca.gov is updated daily.
Public use is not allowed in places such as restaurants and bars, and driving under the influence is illegal.
Cannabis laws in California: the full guide
Reporting by NORML. Read the full story at NORML.
See how